CYP7B1 and metabolic dysfunction-associated steatohepatitis: However, no impact of all tested genotypes (EBI2, CH25H, CYP7B1) on NASH could be detected, arguing against a relevant interaction of gut microbiota dysbiosis and the EBI – oxysterol axis in our murine NASH model.